BackTcr2 Therapeutics Overview

Tcr2 Therapeutics Net Income

Profitability analysis for TCRR.

Quarterly Net Income

-$40.40M
38.72% YoY

As of Mar 2023

Annual Net Income (TTM)

-$163.10M
51.84% YoY

Trailing 12 months ending Mar 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...